Geneoscopy Closes $105M In Financing To Advance Its Noninvasive Multifactor Rna Screening Test For Colorectal Cancer Prevention
Amount Raised
$105 Million
Round Type
Funding Round
St. LouisBiotechnologyHealthcareHealth CareTherapeuticsHealth DiagnosticsDescription
Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced the closing of a Series B financing, raising a total of $105 million through a combination of debt and equity. The round is led by previous investors Lightchain Capital and NT Investments. Other investors in the round include Morningside Ventures, Labcorp, Cultivation Capital, BioGenerator Ventures, and Innovatus Capital Partners.
Quick answer
Geneoscopy raised $105 Million in a Funding Round round, dated November 16, 2021. Geneoscopy is based in St. Louis, Missouri, United States.
- How much did Geneoscopy raise?
- Geneoscopy raised $105 Million in a Funding Round round on November 16, 2021.
- What does Geneoscopy do?
- Geneoscopy is a life sciences company with the mission to empower patients and providers to transform gastrointestinal health through innovative diagnostics.
- Where is Geneoscopy based and how big is it?
- Geneoscopy is based in St. Louis, Missouri, United States. Fundz records about 63 employees.
- Who are the decision-makers at Geneoscopy?
- Fundz holds 1 contact at Geneoscopy. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Geneoscopy that raised within 45 days of this round, from Fundz verified event records.
- Arbutus raised $15M on December 30, 2021.
- Galectin raised an undisclosed amount (Debt Financing) on December 21, 2021.
- Biofrontera raised $15M on December 10, 2021.
- AEON Biopharma raised $30M on December 8, 2021.
- CytoDyn raised $11M on December 3, 2021.
- TuHURA Biosciences raised $5.1M on November 19, 2021.
Who to call at Geneoscopy, and when
A new round usually means Geneoscopy is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Geneoscopy raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Geneoscopy, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Geneoscopy. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Geneoscopy raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Geneoscopy raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.